Last updated: April 5, 2024
Sponsor: Gangnam Severance Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urologic Cancer
Prostate Cancer
Prostate Cancer, Early, Recurrent
Treatment
conventional PEEP
optimized PEEP
Clinical Study ID
NCT05669443
3-2022-0361
Ages 20-70 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 20 - 70 years of age who are scheduled for robotic assisted laparoscopic prostatectomyat the Department of Urology, Gangnam Severance Hospital,
- ASA-PS (American Society of Anesthesiology Body Rating) I-IlI,
- Patients with a BMI of 35 kg/m2 or less
Exclusion
Exclusion Criteria:
- Patients with lung disease
- BMI >35kg/m2
- Patients for whom positive end-tidal pressure cannot be applied (large bullae, severecardiac disease)
- patient refusal
Study Design
Total Participants: 42
Treatment Group(s): 2
Primary Treatment: conventional PEEP
Phase:
Study Start date:
April 03, 2023
Estimated Completion Date:
November 10, 2024
Connect with a study center
Gangnam Severacne Hospital Yonsei University College of Medicine
Seoul,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.